United States · FDA National Drug Code directory
Tofacitinib
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72205-139_25aada50-1f94-495f-9c11-8e2e9f282994
- Product NDC
- 72205-139
- Form
- TABLET, FILM COATED
- Composition / generic term
- Tofacitinib
- Labeler
- Novadoz Pharmaceuticals LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20260603
- Source listing expiry
- 20271231
Source-listed ingredients
- TOFACITINIB CITRATE — 5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 28 TABLET, FILM COATED in 1 BOTTLE (72205-139-28) · 72205-139-28
- 60 TABLET, FILM COATED in 1 BOTTLE (72205-139-60) · 72205-139-60
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →